Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review (Q38072387)

28 August 2017

1 reference

title

Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review (English)

1 reference

28 August 2017

0 references

mesenchymal stem cell

1 reference

Jan Voswinkel

1

1 reference

28 August 2017

Sabine Francois

2

1 reference

28 August 2017

Jean-Marc Simon

3

1 reference

28 August 2017

Marc Benderitter

4

1 reference

28 August 2017

Norbert-Claude Gorin

5

1 reference

28 August 2017

Mohamad Mohty

6

1 reference

28 August 2017

Loïc Fouillard

7

1 reference

28 August 2017

Alain Chapel

8

1 reference

28 August 2017

publication date

1 October 2013

1 reference

Clinical Reviews in Allergy & Immunology

28 August 2017

published in

1 reference

28 August 2017

volume

45

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

180-192

1 reference

https://scigraph.springernature.com/pub.10.1007/s12016-012-8347-6

28 August 2017

exact match

0 references

cites work

Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Immune modulation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Bone marrow-derived mesenchymal stem cells ameliorate autoimmune enteropathy independently of regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Human mesenchymal stem cells modulate B-cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Immunomodulation by mesenchymal stem cells and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Overview of stem cell therapy for Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Overview of biologic therapy for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

How I treat refractory acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Pravastatin limits endothelial activation after irradiation and decreases the resulting inflammatory and thrombotic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Influence of endothelial cells on vascular smooth muscle cells phenotype after irradiation: implication in radiation-induced vascular damages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Transplantation of mesenchymal stem cells to prevent radiation-induced intestinal injury in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Epinal radiotherapy accident: passed, present, future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Securitization of the bi-site radiotherapy activity as part of the resumption of treatments in the Hospital of Epinal by the team of Alexis Vautrin Nancy Cancer Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Assessing global pain severity by self-report in clinical and health services research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

Validation of the Brief Pain Inventory for chronic nonmalignant pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-012-8347-6

The temporal and spatial changes in cell proliferation within the irradiated crypts of the murine small intestine

21 January 2018

1 reference

12 December 2020

Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons

1 reference

12 December 2020

Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis

1 reference

12 December 2020

Effects of transplanted bone marrow mesenchymal stem cells on the irradiated intestine of mice

1 reference

12 December 2020

Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells

1 reference

12 December 2020

Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells

1 reference

12 December 2020

Adipose-derived stem cells in Crohn's rectovaginal fistula

1 reference

12 December 2020

[Mesenchymal stem cells and rheumatism. State of the art]

1 reference

12 December 2020

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

1 reference

12 December 2020

Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction

1 reference

12 December 2020

Producing MSC according GMP: process and controls.

1 reference

12 December 2020

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

1 reference

12 December 2020

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

12 December 2020

Spontaneous human adult stem cell transformation.

1 reference

12 December 2020

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

12 December 2020

Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials

1 reference

12 December 2020

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

1 reference

12 December 2020

Mesenchymal stem cells might be used to induce tolerance in heart transplantation

1 reference

12 December 2020

Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis

1 reference

12 December 2020

Mesenchymal stromal cell-conditioned medium prevents radiation-induced small intestine injury in mice

1 reference

12 December 2020

Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

1 reference

12 December 2020

Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury

1 reference

12 December 2020

Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age

1 reference

12 December 2020

Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G

1 reference

12 December 2020

Use of allogeneic mesenchymal stem cells in the treatment of intestinal inflammatory diseases

1 reference

12 December 2020

Treatment of experimental arthritis by inducing immune tolerance with human adipose-derived mesenchymal stem cells

1 reference

12 December 2020

Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation

1 reference

12 December 2020

Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells

1 reference

12 December 2020

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

12 December 2020

Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art

1 reference

12 December 2020

10.1007/S12016-012-8347-6

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1048339991

0 references

1 reference